Effects of aldosterone and spironolactone on the isolated perfused rat heart

被引:16
作者
Moreau, D
Chardigny, JM
Rochette, L
机构
[1] FAC PHARM DIJON,F-21033 DIJON,FRANCE
[2] INRA,F-21034 DIJON,FRANCE
关键词
aldosterone; cardiac function; rat; spironalactone;
D O I
10.1159/000139412
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aldosterone antagonists are used in the treatment of hypertension, However, the cardiac influences of aldosterone and its antagonists have not been thoroughly investigated, In the present study, we investigated the effects of aldosterone and spironolactone on an isolated rat working heart model, Aldosterone (10(-8) mol/l) decreased the coronary flow and increased aortic flow and cardiac output. Spironolactone (10(-5) mol/l) inhibited these effects. These results suggest that aldosterone directly influences the cardiac function. Spironolactone appears able to inhibit the adverse cardiac effects of aldosterone. The exact mechanisms remain to be elucidated, but the early effects of aldosterone under our experimental conditions on the functional parameters of the heart suggest a nongenomic response including activation of receptors different from those transmitting genomic steroid actions.
引用
收藏
页码:28 / 36
页数:9
相关论文
共 46 条
[1]  
ADLER S, 1970, American Journal of Physiology, V218, P616
[2]  
AGARWAL MK, 1994, PHARMACOL REV, V46, P67
[3]   AN EXTRARENAL MECHANISM OF POTASSIUM ADAPTATION [J].
ALEXANDER, EA ;
LEVINSKY, NG .
JOURNAL OF CLINICAL INVESTIGATION, 1968, 47 (04) :740-+
[4]  
BACCIARELLI C, 1967, ARCH INT PHARMACOD T, V166, P150
[5]  
BERANGER C, 1986, ARCH MAL COEUR VAISS, V79, P1117
[6]  
BEVEGARD S, 1977, ACTA MED SCAND, V202, P373
[7]   REGULATION OF EXTRA-RENAL POTASSIUM HOMEOSTASIS BY ADRENAL HORMONES IN RATS [J].
BIA, MJ ;
TYLER, KA ;
DEFRONZO, RA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1982, 242 (06) :F641-F644
[8]  
BOHR DF, 1958, FED PROC, V17, P17
[9]  
BRIGGS AH, 1959, AM J PHYSIOL, V127, P1161
[10]   ABSENCE OF RELATIONSHIP BETWEEN ANTIARRHYTHMIC EFFECTS OF ANTIDEPRESSANT DRUGS AND LIPID-PEROXIDATION [J].
BRIL, A ;
ABADIE, C ;
BENBAOUALI, A ;
MAUPOIL, V ;
ROCHETTE, L .
PHARMACOLOGY, 1993, 46 (01) :23-32